Alprostadil/Lidocaine

前列地尔/利多卡因

Report date: 2026/02/14 13:58:43

Base Information

Drug NameAlprostadil/Lidocaine
Drug Alias Name前列地尔利多卡因Lidocaine/Alprostadil利多卡因+前列地尔Alprostadil and LidocaineLidocaine and Alprostadil +[9] 
ClassificationSmall molecules
Mechanisms of ActionProstaglandin agonistsSodium channel alpha subunit blockers
TargetsProstaglandinSodium channel alpha subunit
Therapy Area/IndicationsPremature Ejaculation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AlprostadilLidocaine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApricus Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApricus Biosciences
Active IndicationsN/A
Inactive IndicationsPremature Ejaculation

Other Information

ATC CodeN/A
Related LinksN/A